Turning Point Therapeutics Granted Sixth Regulatory Designation for Repotrectinib
Fast-Track Designation Granted by FDA in ROS1-Positive Advanced Non-Small Cell Lung Cancer Patients Pretreated With…
Month: August 2021
TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand
MALVERN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a…
Gain Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Business Update
Announced Multi-Target Drug Discovery Collaboration with Zentalis Pharmaceuticals in Oncology— Granted Two Patents for Compounds…
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma
WATERTOWN, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
Prometheus Biosciences Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Progress
– Initiated Phase 2 study of PRA023 and its companion diagnostic in Ulcerative Colitis (UC)…
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
Company Shows Continued Progress Demonstrating Differentiation of RAS(ON) Inhibitors, Targeting Additional RAS Variants and Progressing…
Intrommune Therapeutics Appoints Moises V. “Moe” Vela, Jr. to its Business Advisory Board
Long-time Washington Insider is Uniquely Positioned at the Intersection of Law, Politics, Business, and Finance…
BioVie Inc. Announces Closing of Public Offering of Common Stock
SANTA MONICA, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate
Saint-Herblain (France), August 11th, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Ultimovacs ASA: Invitation to Second Quarter 2021 Results Webcast Presentation
OSLO, Norway, Aug. 11, 2021 (GLOBE NEWSWIRE) — Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical…
Genmab Announces Financial Results for the First Half of 2021
August 11, 2021; Copenhagen, Denmark; Interim Report for the First Half of 2021 Highlights The…
Ultimovacs ASA: Invitation to second quarter 2021 results webcast presentation
Oslo, 11 August 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune…
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19
First-in-human study evaluating recombinant hyperimmunes SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) —…
Plus Therapeutics to Present Data from Two Studies Supporting the Treatment of Leptomeningeal Metastases with Rhenium-186 Nanoliposome
AUSTIN, Texas, Aug. 11, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Life Sciences BC names Novateur Ventures Strategic Partner of the Year
VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — In a recent announcement Life Sciences…
Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide
– Second human trial to be conducted as part of a long-term Master Service Agreement…
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including…
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including…
Shaw Communications Applauds Expansion of Federal Connecting Families Initiative
CALGARY, Alberta, Aug. 11, 2021 (GLOBE NEWSWIRE) — Shaw Communications Inc. today said it supports…
The Next Chapter in Mobile Innovation: Unfold Your World with the Galaxy Z Fold3 5G and Galaxy Z Flip3 5G
Samsung sets a new standard for mobile experiences with powerful premium foldable smartphones complemented by…